Business Context and Reporting Period
This Form 8-K filing by Molina Healthcare, Inc. reports a corporate governance event dated December 29, 2017. The filing addresses changes to the composition of the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to non-financial corporate governance matters.
Material Changes
- Director Reassignment: Joseph M. Zubretsky was reassigned from Class I to Class III of the Board of Directors.
- Board Size Adjustment: The vacancy created in Class I by Mr. Zubretsky's move was closed, fixing the total board size at nine members.
- Reasoning: The reassignment was made to equalize the size of the three board classes following the resignation of Dr. J. Mario Molina from Class III on December 12, 2017.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document strictly details the administrative reassignment of a director to comply with the Company's Certificate of Incorporation and NYSE Listing Standards.
Key Facts for Investor Verification
- Confirm the current composition and class distribution of the Molina Healthcare Board of Directors.
- Verify the effective date of Dr. J. Mario Molina's resignation (December 12, 2017) and its impact on board structure.
- Ensure the total board size remains fixed at nine members as stated in the filing.